Rare lephants
Screener

Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Feb 14, 2023 SC 13G/A
SC 13G/A Feb 14, 2023 SC 13G/A
SC 13G/A Feb 14, 2023
SC 13G/A Feb 14, 2023 AMENDMENT NO. 3
SC 13G/A Feb 14, 2023 AMENDMENT NO. 2 TO THE SCHEDULE 13G
SC 13G/A Feb 14, 2023
SC 13G/A Feb 14, 2023 AMENDMENT NO. 1 TO SCHEDULE 13G
4 Feb 10, 2023 FORM 4 SUBMISSION
4 Feb 10, 2023 FORM 4 SUBMISSION
4 Feb 10, 2023 FORM 4 SUBMISSION
4 Feb 10, 2023 FORM 4 SUBMISSION
SC 13G Feb 9, 2023 SCHEDULE 13G
4 Feb 7, 2023 FORM 4 SUBMISSION
3 Feb 7, 2023 FORM 3 SUBMISSION
4/A Feb 7, 2023 FORM 4/A SUBMISSION
8-K Feb 6, 2023 8-K
4 Feb 3, 2023 FORM 4 SUBMISSION
SC 13G Feb 3, 2023
SC 13G/A Jan 26, 2023
4 Jan 25, 2023 FORM 4 SUBMISSION
4 Jan 18, 2023 FORM 4 SUBMISSION
4 Jan 11, 2023 FORM 4 SUBMISSION
8-K Jan 9, 2023 8-K
4 Dec 22, 2022 FORM 4 SUBMISSION
4 Dec 19, 2022 FORM 4 SUBMISSION
← Newer Page 10 of 33 · 815 filings Older →